Schematic showing how antisense oligonucleotides restore FKTN protein and α-DG functions in cell-based experiments (IMAGE)
Caption
RNAi-based treatment restores normal FKTN protein production and alpha-dystroglycan glycosylation in cells derived from patients with Fukuyama Muscular Dystrophy carrying the deep intronic variant
Credit
Mariko Taniguchi-Ikeda from Fujita Health University
Usage Restrictions
You are free to share and adapt the material. Attribution is required.
License
Original content